Pars planitis: epidemiology, treatment, and association with multiple sclerosis

Area of Science:

• Ophthalmology
• Neurology
• Immunology

Background:

• Pars planitis is an inflammatory condition of the eye.
• The association between pars planitis and multiple sclerosis (MS) requires further investigation.
• Understanding the clinical characteristics and visual outcomes of pars planitis is crucial for patient management.

Purpose of the Study:

• To determine the clinical characteristics, treatment, and visual outcome of patients with pars planitis.
• To evaluate the association between pars planitis and multiple sclerosis (MS).
• To assess the utility of magnetic resonance imaging (MRI) in diagnosing MS in pars planitis patients.

Main Methods:

• Retrospective study of 44 pars planitis patients (1986-1999) analyzing demographics, visual acuity (VA), follow-up, and treatments.
• Prospective study of 21 pars planitis patients to assess for MS presence.
• Magnetic resonance imaging (MRI) performed on prospective cohort to detect demyelinating lesions.

Main Results:

• Common complications in pars planitis included macular edema (47.7%), vitreous opacities (38.6%), and papillitis (38.6%).
• Most patients (90.9%) achieved a final bilateral VA better than 20/40.
• In the prospective study, 47.6% showed demyelinating lesions on MRI, and 33.3% were diagnosed with MS; MS diagnosis was more frequent in patients over 25.

Conclusions:

• Pars planitis patients generally have a good visual prognosis with appropriate treatment.
• A high prevalence of demyelinating lesions suggests a significant association between pars planitis and MS.
• Consider MRI screening for MS in pars planitis patients, particularly those over 25 years of age.